Docetaxel-ST1481 sequence exerts a potent cytotoxic activity on hormone-resistant prostate cancer cells by reducing drug resistance-related gene expression

  • Docetaxel and ST1481 in Prostate Cancer
  • Francesco Fabbri, Giovanni Brigliadori, Silvia Carloni, Paola Ulivi, Anna Tesei, Rosella Silvestrini, Dino Amadori, Wainer Zoli
  • The Prostate, September 2009, Wiley
  • DOI: 10.1002/pros.21055

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

The following have contributed to this page: Dr Anna Tesei